Date:5/18/2009

9 Other Assets Land use right, net of accumulated amortization 1,453,481 1,531,555 Notes receivable 1,066,449 998,502 Long-term prepayments 818,882 1,150,082 Total other assets 3,338,812 3,680,139 Total Assets $ 26,364,737 $ 20,253,041 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Accounts payable $ 1,425,217 $ 725,680 Accrued expenses and other payables 784,142 809,463 Payable to related parties 18,134 -- Total current liabilities 2,227,493 1,535,143 Long-term payable - land use right 1,464,575 1,459,137 Minority Interest 3,447,892 2,282,109 Stockholders' Equity: Preferred stock, $0.001 par value, 1,000,000 shares authorized, - 0 - shares issued and outstanding at March 31,2009 and June 30, 2008 -- -- Common stock, $0.001 par value, 74,000,000 and 74,000,000 shares authorized, 30,000,000 and 30,000,000 shares issued and outstanding at March 31, 2009 and June 30, 2008, respectively 30,000 30,000 Additional paid-in-capital 3,846,035 3,846,035 Statutory surplus reserve and common welfare fund 2,643,339 1,837,187 Retained earnings 11,568,237 8,009,800 Accumulated other comprehensive income 1,137,166 1,253,630 Total stockholders' equity 19,224,777 14,976,652 Total Liabilities and
'/>"/>

SOURCE China Dasheng Biotechnology Company Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8
Related biology technology :

1. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
4. China-Biotics, Inc. Signs Intention Agreement to Supply Probiotics to Bright Dairy & Food Co., Ltd.
5. China Technology Announces New Chief Financial Officer
6. China Medical Technologies Reports First Quarter Financial Results
7. China Medical Technologies to Participate in Credit Suisses 2007 Asian Technology Conference
8. China Technology Announces Entry to the Solar Energy Sector
9. China Sky One Medical Receives $1.5 Million Government Grant to Further Develop Six New Cancer Products
10. Kiwa Bio-Tech Named Recommended Brand by the China Green Food Association
11. China Kangtai Cactus Biotech, Inc. Announces Plans for New Product Launch